scholarly article | Q13442814 |
P50 | author | Ichiko Kinjyo | Q58883938 |
P2093 | author name string | S Kato | |
T Yoshida | |||
Y Nomura | |||
A Yoshimura | |||
M Kubo | |||
T Hanada | |||
H Yasukawa | |||
Y Seki | |||
H Mimata | |||
S Minoguchi | |||
P2860 | cites work | A new protein containing an SH2 domain that inhibits JAK kinases | Q24313242 |
Cloning and characterization of novel CIS family genes | Q24321480 | ||
cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family | Q24336422 | ||
Inhibition of Transcription Elongation by the VHL Tumor Suppressor Protein | Q24336629 | ||
Elongin (SIII): A Multisubunit Regulator of Elongation by RNA Polymerase II | Q24336681 | ||
Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C | Q24336712 | ||
The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop | Q24533774 | ||
STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells | Q24534351 | ||
The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation | Q24654107 | ||
CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2 | Q28140132 | ||
Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain | Q28140535 | ||
Gigantism in mice lacking suppressor of cytokine signalling-2 | Q28140549 | ||
SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality | Q28144528 | ||
SOCS3 is essential in the regulation of fetal liver erythropoiesis | Q28144536 | ||
Negative regulation of cytokine signaling pathways | Q28145643 | ||
Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase | Q28506124 | ||
STATs and gene regulation | Q29547796 | ||
Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice | Q31949951 | ||
Control of B cell development by Ras-mediated activation of Raf. | Q33887809 | ||
Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice | Q33959559 | ||
The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families | Q35211894 | ||
CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation | Q36376179 | ||
Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling | Q36638911 | ||
Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. | Q36735213 | ||
Expression of constitutively active IkappaB beta in T cells of transgenic mice: persistent NF-kappaB activity is required for T-cell immune responses | Q39631389 | ||
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. | Q40816941 | ||
Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis | Q42157047 | ||
The influence of the MAPK pathway on T cell lineage commitment | Q46660975 | ||
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. | Q52174469 | ||
Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A | Q71215744 | ||
CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells | Q77540472 | ||
One ring to rule a superfamily of E3 ubiquitin ligases | Q77752816 | ||
P433 | issue | 44 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 40746-40754 | |
P577 | publication date | 2001-08-24 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box | |
P478 | volume | 276 |
Q30856129 | Activation of SOCS-3 by resistin |
Q37100724 | BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. |
Q35643695 | CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling. |
Q37168136 | Computational models of the JAK1/2-STAT1 signaling |
Q40477164 | Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. |
Q44277958 | Control mechanism of JAK/STAT signal transduction pathway |
Q35681609 | Coreceptor gene imprinting governs thymocyte lineage fate. |
Q36219805 | Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation |
Q40563242 | Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling |
Q40340377 | Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophages |
Q92760300 | E-protein-regulated expression of CXCR4 adheres preselection thymocytes to the thymic cortex |
Q46943877 | Elongin B/C recruitment regulates substrate binding by CIS. |
Q47637082 | Identification of lineage-specifying cytokines that signal all CD8+-cytotoxic-lineage-fate 'decisions' in the thymus. |
Q28505531 | Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation |
Q39440197 | Negative Regulation of Cytokine Signaling in Immunity |
Q36231107 | Negative regulation of cytokine and TLR signalings by SOCS and others |
Q24530173 | Principles of interleukin (IL)-6-type cytokine signalling and its regulation |
Q37064933 | Prolactin regulation of mammary gland development. |
Q35096707 | Regulation of cytokine receptor signaling by SOCS1. |
Q40375009 | Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalization |
Q41821133 | Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin-proteasome-dependent degradation of rhodopsin during retinal inflammation |
Q37527082 | SOCS-1 localizes to the microtubule organizing complex-associated 20S proteasome |
Q47777274 | SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses |
Q24537559 | SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation |
Q40366547 | SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation |
Q63383863 | SOCS3 is required to temporally fine-tune photoreceptor cell differentiation |
Q28508827 | STAP-2/BKS, an adaptor/docking protein, modulates STAT3 activation in acute-phase response through its YXXQ motif |
Q36871967 | STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses |
Q36562969 | Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. |
Q79073423 | Suppressor of Cytokine Signaling-1 Is Essential for Suppressing Dendritic Cell Activation and Systemic Autoimmunity |
Q40522793 | Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines |
Q37455362 | Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function |
Q39131158 | Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy. |
Q24321847 | The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins |
Q35989418 | The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo |
Q39741176 | The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury |
Q45345537 | The transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing the SOCS suppressors of cytokine signaling. |
Q51461656 | Timing and duration of MHC I positive selection signals are adjusted in the thymus to prevent lineage errors. |
Q43202271 | Tumor necrosis factor-a augments lipopolysaccharide-induced suppressor of cytokine signalling 3 (SOCS-3) protein expression by preventing the degradation |
Q40642728 | Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation |
Q34742146 | Viral exploitation of host SOCS protein functions |
Search more.